Amexdrug Corporation (AXRX) Stock
Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Amexdrug Corporation
Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale. The company's operations are divided into two main divisions: Distribution and Health and Beauty Products. Its extensive distribution network encompasses a wide range of items, including prescription and over-the-counter medications, various non-drug products, and health and beauty essentials. Amexdrug also provides services in private manufacturing and labeling. Specific product lines manufactured and sold by the company, often under its Sponix brand, include facial and body creams, arthritic pain relief treatments, and hair and nail care products. These goods are supplied to a diverse clientele such as pharmacies, beauty salons, beauty supply outlets, and other retail establishments. Within the state of California, Amexdrug's distribution channels primarily target independent pharmacies, extending secondarily to smaller pharmacy chains, alternative care facilities, and various wholesalers and retailers. The company adopted the name Amexdrug Corporation in April 2000, changing from its previous identity as Harlyn Products, Inc., to reflect its strategic focus on pharmaceutical sales.
Amexdrug Corporation (AXRX) stock trades at $0.00 with a market capitalization of $33882. The stock is valued at a price-to-earnings (P/E) ratio of 0.50, price-to-book of 0.02, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Amexdrug Corporation generates a return on equity (ROE) of 0.00%, return on capital employed of 6.76%, an operating margin of 5.29%, a net profit margin of 1.59%.
Official website: www.amexdrug.com